{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T14:17:15Z","timestamp":1793110635513,"version":"4.5.0"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12272-9","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T16:04:56Z","timestamp":1764950696000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pathogenic mechanisms and resistance profiles of microbial pulmonary infections in lung cancer: a systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"Milad","family":"Sheervalilou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Ghanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Arabfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"12272_CR1","doi-asserted-by":"crossref","unstructured":"Rafeq R, Igneri LA. Infectious pulmonary diseases. Emergency medicine clinics of North America. 2022;40(3):503\u201318.","DOI":"10.1016\/j.emc.2022.05.005"},{"key":"12272_CR2","doi-asserted-by":"crossref","unstructured":"Eltobgy M, Johns F, Bednash JS. Clinical manifestations and pathogenesis of COVID-19 pulmonary disease. In: Zhao Y, editor. Boca Raton: CRC Press; 2024. p. 211\u2013234.","DOI":"10.1201\/9781003355243-15"},{"issue":"7","key":"12272_CR3","doi-asserted-by":"publisher","first-page":"e00442","DOI":"10.1128\/iai.00442-22","volume":"91","author":"S Lempke","year":"2023","unstructured":"Lempke S, May D, Ewald SE. Microbial pathogenesis in the era of spatial omics. Infect Immun. 2023;91(7):e00442\u201322.","journal-title":"Infect And Immun"},{"key":"12272_CR4","doi-asserted-by":"crossref","unstructured":"Febbo J, Dako F. Pulmonary infection. Clin Chest Med. 2024.","DOI":"10.1016\/j.ccm.2024.02.009"},{"issue":"1","key":"12272_CR5","doi-asserted-by":"publisher","first-page":"25\u2013","DOI":"10.1038\/s41572-021-00259-0","volume":"7","author":"A Torres","year":"2021","unstructured":"Torres A, Cilloniz C, Niederman MS, Men\u00e9ndez R, Chalmers JD, Wunderink RG, et al. Pneumonia. Nat Rev Dis Primers. 2021;7(1):25\u2013.","journal-title":"Nat Rev Disease Primers"},{"issue":"10258","key":"12272_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"C Abbafati","year":"2020","unstructured":"Abbafati C, Abbas KM, Abbasi M, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. The Lancet. 2020;396(10258):1204\u201322.","journal-title":"The Lancet"},{"issue":"5","key":"12272_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa1500245","volume":"373","author":"S Jain","year":"2015","unstructured":"Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired pneumonia requiring hospitalization among U.S. Adults. N Engl J Med. 2015;373(5):415\u201327.","journal-title":"N Engl J Med"},{"issue":"11","key":"12272_CR8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. The Lancet Infect Dis. 2018;18(11):1191\u2013210.","journal-title":"The Lancet Infect Dis"},{"issue":"Suppl 7","key":"12272_CR9","first-page":"S570","volume":"222","author":"T Shi","year":"2021","unstructured":"Shi T, Denouel A, Tietjen AK, Lee JW, Falsey AR, Demont C, et al. Global and regional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis. J Infect Dis. 2021;222(Suppl 7):S570\u20136.","journal-title":"J Infect Dis"},{"issue":"10159","key":"12272_CR10","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GA Roth","year":"2018","unstructured":"Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of disease study 2017. The Lancet. 2018;392(10159):1736\u201388.","journal-title":"The Lancet"},{"issue":"7","key":"12272_CR11","doi-asserted-by":"publisher","first-page":"e0200504","DOI":"10.1371\/journal.pone.0200504","volume":"13","author":"C Cill\u00f3niz","year":"2018","unstructured":"Cill\u00f3niz C, Liapikou A, Martin-Loeches I, Garc\u00eda-Vidal C, Gabarr\u00fas A, Ceccato A, et al. Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia. PLoS ONE. 2018;13(7):e0200504\u2013e.","journal-title":"PLoS One"},{"issue":"5","key":"12272_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1164\/rccm.201501-0140OC","volume":"192","author":"DT Eurich","year":"2015","unstructured":"Eurich DT, Marrie TJ, Minhas-Sandhu JK, Majumdar SR. Ten-year mortality after community-acquired pneumonia: a prospective cohort. Am J Respir Crit Care Med. 2015;192(5):597\u2013604.","journal-title":"Am J Respir And Crit Care Med"},{"issue":"11","key":"12272_CR13","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1093\/cid\/cix647","volume":"65","author":"JA Ramirez","year":"2017","unstructured":"Ramirez JA, Wiemken TL, Peyrani P, Arnold FW, Kelley R, Mattingly WA, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806\u201312.","journal-title":"Clin Infect Dis"},{"key":"12272_CR14","doi-asserted-by":"publisher","first-page":"38097\u2013","DOI":"10.1038\/srep38097","volume":"6","author":"K Komiya","year":"2016","unstructured":"Komiya K, Rubin BK, Kadota JI, Mukae H, Akaba T, Moro H, et al. Prognostic implications of aspiration pneumonia in patients with community acquired pneumonia: a systematic review with meta-analysis. Sci Rep. 2016;6:38097\u2013.","journal-title":"Sci Rep"},{"issue":"5","key":"12272_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1513\/AnnalsATS.201709-728OC","volume":"15","author":"PK Lindenauer","year":"2018","unstructured":"Lindenauer PK, Strait KM, Grady JN, Ngo CK, Parisi ML, Metersky M, et al. Variation in the diagnosis of aspiration pneumonia and association with hospital pneumonia outcomes. Ann Am Thorac Soc. 2018;15(5):562\u201369.","journal-title":"Ann Of The Am Thorac Soc"},{"issue":"3","key":"12272_CR16","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/MCP.0b013e32835f27be","volume":"19","author":"F Barbier","year":"2013","unstructured":"Barbier F, Andremont A, Wolff M, Bouadma L. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med. 2013;19(3):216\u201328.","journal-title":"Curr Opin In Pulm Med"},{"issue":"5","key":"12272_CR17","first-page":"385","volume":"24","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Vena A, Graziano E, Russo A, Peghin M. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant\/extensively drug-resistant\/pandrug-resistant bacteria. Curr Opin Crit Care. 2018;24(5):385\u201393.","journal-title":"Curr Opin in Crit Care"},{"issue":"4","key":"12272_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/resp.12978","volume":"22","author":"C Cilloniz","year":"2017","unstructured":"Cilloniz C, Ewig S, Gabarrus A, Ferrer M, Puig de la Bella Casa J, Mensa J, et al. Seasonality of pathogens causing community-acquired pneumonia. Respirology. 2017;22(4):778\u201385.","journal-title":"Respirology"},{"issue":"2","key":"12272_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4103\/lungindia.lungindia_288_17","volume":"35","author":"RA Para","year":"2018","unstructured":"Para RA, Fomda BA, Jan RA, Shah S, Koul PA. Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia. Lung India. 2018;35(2):108\u201315.","journal-title":"Lung India"},{"issue":"17","key":"12272_CR20","first-page":"2967","volume":"125","author":"T Ll","year":"2012","unstructured":"Ll T, Dr Bj H, Lx H, Wei L, Hm X, Bq W, et al. Etiology and antimicrobial resistance of community-acquired pneumonia in adult patients in China. Chin Med J. 2012;125(17):2967\u201372.","journal-title":"Chin Med J"},{"issue":"4","key":"12272_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1055\/s-0040-1709992","volume":"41","author":"H He","year":"2020","unstructured":"He H, Wunderink RG. Staphylococcus aureus pneumonia in the community. Semin Respir Crit Care Med. 2020;41(4):470\u201379.","journal-title":"Semin Respir And Crit Care Med"},{"key":"12272_CR22","doi-asserted-by":"publisher","first-page":"894644\u2013","DOI":"10.3389\/fcimb.2022.894644","volume":"12","author":"CS Palmer","year":"2022","unstructured":"Palmer CS, Kimmey JM. Neutrophil recruitment in pneumococcal pneumonia. Front Cell Infect Microbiol. 2022;12:894644\u2013.","journal-title":"Front Cellular And Infect Microbiol"},{"issue":"2","key":"12272_CR23","doi-asserted-by":"publisher","first-page":"GPP3\u20130007","DOI":"10.1128\/microbiolspec.GPP3-0007-2018","volume":"7","author":"VN Raabe","year":"2019","unstructured":"Raabe VN, Shane AL. Group B Streptococcus (streptococcus agalactiae). Microbiol Spectr. 2019;7(2):GPP3\u20130007\u20132018.","journal-title":"Microbiol Spectr"},{"issue":"Suppl 1","key":"12272_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.37201\/req\/s01.09.2023","volume":"36","author":"JT Ramos Amador","year":"2023","unstructured":"Ramos Amador JT, Berzosa S\u00e1nchez A, Ill\u00e1n Ramos M. Group a Streptococcus invasive infection in children: epidemiologic changes and implications. Revista Esp de Quimioterapia. 2023;36(Suppl 1):33\u201336.","journal-title":"Revista Esp de Quimioterapia"},{"issue":"6","key":"12272_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/01.NURSE.0000918540.45884.d3","volume":"53","author":"SJ Schweon","year":"2023","unstructured":"Schweon SJ. Diphtheria update. Nursing. 2023;53(6):46\u201349.","journal-title":"Nursing"},{"issue":"6\u20137","key":"12272_CR26","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.micinf.2020.05.020","volume":"22","author":"M Wei","year":"2020","unstructured":"Wei M, Yongjie Z, Zhuoyu Q, Biao Y, Xi J, Wei J, et al. Pneumonia caused by mycobacterium tuberculosis. Microbes Infect. 2020;22(6\u20137):278\u201384.","journal-title":"Microbes And Infect"},{"issue":"3","key":"12272_CR27","first-page":"e00164","volume":"36","author":"BM Chamorro","year":"2023","unstructured":"Chamorro BM, De Luca K, Swaminathan G, Longet S, Mundt E, Paul S. Bordetella bronchiseptica and bordetella pertussis: similarities and differences in infection, immuno-modulation, and vaccine considerations. Clin Microbiol Rev. 2023;36(3):e00164\u201322.","journal-title":"Clin Microbiol Rev"},{"key":"12272_CR28","doi-asserted-by":"publisher","first-page":"903682\u2013","DOI":"10.3389\/fcimb.2022.903682","volume":"12","author":"IR Chen","year":"2022","unstructured":"Chen IR, Lin SN, Wu XN, Chou SH, Wang FD, Lin YT. Clinical and microbiological characteristics of bacteremic pneumonia caused by klebsiella pneumoniae. Front Cell Infect Microbiol. 2022;12:903682\u2013.","journal-title":"Front Cellular And Infect Microbiol"},{"issue":"10","key":"12272_CR29","doi-asserted-by":"publisher","first-page":"001442\u2013","DOI":"10.1099\/jmm.0.001442","volume":"70","author":"NK Fry","year":"2021","unstructured":"Fry NK, Campbell H, Amirthalingam G. JMM profile: bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable. J Med Microbiol. 2021;70(10):001442\u2013.","journal-title":"J Med Microbiol"},{"issue":"3","key":"12272_CR30","doi-asserted-by":"publisher","first-page":"1907\u2013","DOI":"10.3390\/ijerph19031907","volume":"19","author":"FF Graham","year":"2022","unstructured":"Graham FF, Finn N, White P, Hales S, Baker MG. Global perspective of Legionella infection in community-acquired pneumonia: a systematic review and meta-analysis of observational studies. Int J Environ Res Public Health. 2022;19(3):1907\u2013.","journal-title":"Int J Environ Res And Public Health"},{"key":"12272_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev-pathmechdis-012419-032742","volume":"15","author":"S Mondino","year":"2020","unstructured":"Mondino S, Schmidt S, Rolando M, Escoll P, Gomez-Valero L, Buchrieser C. Legionnaires\u2019 disease: state of the art knowledge of pathogenesis mechanisms of legionella. Annu Rev Pathol Mech Dis. 2020;15:439\u201366.","journal-title":"Annu Rev Pathol: Mechanisms Of Disease"},{"issue":"6","key":"12272_CR32","doi-asserted-by":"publisher","first-page":"106450\u2013","DOI":"10.1016\/j.ijantimicag.2021.106450","volume":"58","author":"R Recio","year":"2021","unstructured":"Recio R, Viedma E, Gonz\u00e1lez-Bod\u00ed S, Villa J, Orellana M\u00c1, Manche\u00f1o-Losa M, et al. Clinical and bacterial characteristics of pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumonia. Int J Antimicrob Agents. 2021;58(6):106450\u2013.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"12272_CR33","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1513\/AnnalsATS.201906-459OC","volume":"18","author":"E Sando","year":"2021","unstructured":"Sando E, Suzuki M, Ishida M, Yaegashi M, Aoshima M, Ariyoshi K, et al. Definitive and indeterminate pseudomonas aeruginosa infection in adults with community-acquired pneumonia. Ann Am Thorac Soc. 2021;18(9):1475\u201381.","journal-title":"Ann Of The Am Thorac Soc"},{"key":"12272_CR34","doi-asserted-by":"publisher","first-page":"104205\u2013","DOI":"10.1016\/j.meegid.2020.104205","volume":"80","author":"S Wen","year":"2020","unstructured":"Wen S, Feng D, Chen D, Yang L, Xu Z. Molecular epidemiology and evolution of haemophilus influenzae. Infect Genet Evol. 2020;80:104205\u2013.","journal-title":"Infect, Genet And Evol"},{"issue":"25","key":"12272_CR35","doi-asserted-by":"publisher","first-page":"33158","DOI":"10.1007\/s11356-021-13103-5","volume":"28","author":"S Zhang","year":"2021","unstructured":"Zhang S, Chen X, Wang J, Dai C, Gou Y, Wang H. Particulate air pollution and respiratory haemophilus influenzae infection in Mianyang, southwest China. Environ Sci Pollut Res. 2021;28(25):33158\u201364.","journal-title":"Environ Sci Pollut Res"},{"key":"12272_CR36","doi-asserted-by":"publisher","first-page":"1524\u2013","DOI":"10.3389\/fimmu.2019.01524","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Lu G, Meng G. Pathogenic fungal infection in the lung. Front Immunol. 2019;10:1524\u2013.","journal-title":"Front Immunol"},{"key":"12272_CR37","first-page":"100972\u2013","volume":"43","author":"C Zhang","year":"2024","unstructured":"Zhang C, Fu X, Liu Y, Zhao H, Wang G. Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019. The Lancet Reg Health - West Pac. 2024;43:100972\u2013.","journal-title":"The Lancet Reg Health - West Pac"},{"issue":"11","key":"12272_CR38","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","volume":"68","author":"S Aliberti","year":"2013","unstructured":"Aliberti S, Cilloniz C, Chalmers JD, Zanaboni AM, Cosentini R, Tarsia P, et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective. Thorax. 2013;68(11):997\u201399.","journal-title":"Thorax"},{"issue":"4","key":"12272_CR39","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/thx.2010.143982","volume":"66","author":"C Cill\u00f3niz","year":"2011","unstructured":"Cill\u00f3niz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarr\u00fas A, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011;66(4):340\u201346.","journal-title":"Thorax"},{"issue":"5","key":"12272_CR40","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis. 2016;63(5):e61\u2013111.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"12272_CR41","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/518460","volume":"28","author":"DJ Weber","year":"2007","unstructured":"Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of Ventilator\u2013associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28(7):825\u201331.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"12272_CR42","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA: A Cancer J For Clinicians"},{"issue":"8","key":"12272_CR43","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, et al. Lung cancer statistics, 2023. Cancer. 2024;130(8):1330\u201348.","journal-title":"Cancer"},{"key":"12272_CR44","first-page":"[1","volume-title":"Evolution of knowledge of the smoking epidemic","author":"R Doll","year":"2010","unstructured":"Doll R. Evolution of knowledge of the smoking epidemic. Oxford University Press; 2010. p. [1\u201312]."},{"issue":"1","key":"12272_CR45","doi-asserted-by":"publisher","first-page":"8\u2013","DOI":"10.5334\/aogh.2419","volume":"85","author":"JA Barta","year":"2019","unstructured":"Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8\u2013.","journal-title":"Ann Of Global Health"},{"issue":"5","key":"12272_CR46","first-page":"750","volume":"47","author":"Y Honda","year":"2020","unstructured":"Honda Y. Lung cancer and respiratory infections. JPN J Cancer Chemother. 2020;47(5):750\u201353.","journal-title":"Jpn J Cancer And Chemother"},{"issue":"10","key":"12272_CR47","doi-asserted-by":"publisher","first-page":"356\u2013","DOI":"10.3390\/jcm7100356","volume":"7","author":"S Skeoch","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift A, Oldroyd A, Johns C, Hayton C, et al. Drug-induced interstitial lung disease: a systematic review. J Clin Med. 2018;7(10):356\u2013.","journal-title":"J Clin Med"},{"issue":"1","key":"12272_CR48","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.4110\/in.2020.20.e9","volume":"20","author":"J Choi","year":"2020","unstructured":"Choi J, Lee SY. Clinical characteristics and treatment of immune-related adverse events of immune checkpoint inhibitors. Immune Network. 2020;20(1):e9\u2013e.","journal-title":"Immune Network"},{"issue":"1","key":"12272_CR49","doi-asserted-by":"publisher","first-page":"402\u2013","DOI":"10.1186\/s12890-023-02681-4","volume":"23","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li J, Wu Q, Chang Q, Guo S. Pathogen distribution in pulmonary infection in Chinese patients with lung cancer: a systematic review and meta-analysis. BMC Pulm Med. 2023;23(1):402\u2013.","journal-title":"BMC Pulm Med"},{"key":"12272_CR50","doi-asserted-by":"crossref","unstructured":"Puga MEDS, Atallah \u00c1N. Cochrane library: the best evidence within everyone\u2019s reach. 2020;355\u201358.","DOI":"10.1590\/1516-3180.2020.138527102020"},{"issue":"10","key":"12272_CR51","first-page":"2127","volume":"18","author":"Z Munn","year":"2019","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Database System Rev Implement Rep. 2019;18(10):2127\u201333.","journal-title":"JBI Database Of Systematic Rev And Implementation Rep"},{"key":"12272_CR52","doi-asserted-by":"publisher","first-page":"108602\u2013","DOI":"10.1016\/j.envint.2024.108602","volume":"186","author":"JPT Higgins","year":"2024","unstructured":"Higgins JPT, Morgan RL, Rooney AA, Taylor KW, Thayer KA, Silva RA, et al. A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ Int. 2024;186:108602\u2013.","journal-title":"Environ Int"},{"issue":"1","key":"12272_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55\u201361.","journal-title":"Res Synth Methods"},{"issue":"2","key":"12272_CR54","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.toxlet.2009.05.013","volume":"189","author":"K Schneider","year":"2009","unstructured":"Schneider K, Schwarz M, Burkholder I, Kopp-Schneider A, Edler L, Kinsner-Ovaskainen A, et al. \u201cToxRtool\u201d, a new tool to assess the reliability of toxicological data. Toxicol Lett. 2009;189(2):138\u201344.","journal-title":"Toxicol Lett"},{"issue":"1","key":"12272_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, Rovers MM, De Vries RBM, Leenaars M, Ritskes-Hoitinga M, Langendam MW. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14(1):43.","journal-title":"BMC Med Res Methodol"},{"key":"12272_CR56","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71\u2013n.","journal-title":"The BMJ"},{"issue":"4","key":"12272_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3892\/ol.2024.14287","volume":"27","author":"D Zhang","year":"2024","unstructured":"Zhang D, Jingjing JIN, Jianying DOU, Huang Y, Zhang H. Impact on hospitalization and infection patterns of advanced lung cancer with lower respiratory tract infections: targeted therapy vs. chemoradiotherapy. Oncol Lett. 2024;27(4):154.","journal-title":"Oncol Lett"},{"issue":"12","key":"12272_CR58","first-page":"1408","volume":"34","author":"DY Su","year":"2022","unstructured":"Su DY, Lin ZA, Qin WJ, Guo QH, Hao LX. Pathogen spectrum and drug resistance in pulmonary infections among lung cancer patients following radiochemotherapy. Chin J Microecol. 2022;34(12):1408\u201311.","journal-title":"Chin J Microecol"},{"issue":"9","key":"12272_CR59","doi-asserted-by":"publisher","first-page":"10005","DOI":"10.21037\/apm-21-2364","volume":"10","author":"Y Chen","year":"2021","unstructured":"Chen Y, Wen F, Chen H, Zhao Y, Ding L, Lu W, et al. Analysis of the pathogenic bacteria, drug resistance, and risk factors of postoperative infection in patients with non-small cell lung cancer. Ann Palliative Med. 2021;10(9):10005\u201312.","journal-title":"Ann Of Palliative Med"},{"issue":"8","key":"12272_CR60","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.21037\/jtd-20-928","volume":"12","author":"H Liu","year":"2020","unstructured":"Liu H, Liu B, Zheng F, Chen X, Ye L, He Y. Distribution of pathogenic bacteria in lower respiratory tract infection in lung cancer patients after chemotherapy and analysis of integron resistance genes in respiratory tract isolates of uninfected patients. J Thorac Dis. 2020;12(8):4216\u201323.","journal-title":"J Thorac Disease"},{"issue":"5","key":"12272_CR61","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.21037\/jtd.2020.04.49","volume":"12","author":"AJ Patel","year":"2020","unstructured":"Patel AJ, Nightingale P, Naidu B, Drayson MT, Middleton GW, Richter A. Characterising the impact of pneumonia on outcome in non-small cell lung cancer: identifying preventative strategies. J Thorac Dis. 2020;12(5):2236\u201346.","journal-title":"J Thorac Disease"},{"issue":"12","key":"12272_CR62","first-page":"772","volume":"22","author":"Q Bao","year":"2019","unstructured":"Bao Q, Zhou H, Chen X, Yang Q, Zhou J. Characteristics and influencing factors of pathogenic bacteria in lung cancer chemotherapy combined with nosocomial pulmonary infection. Chin J Lung Cancer. 2019;22(12):772\u201378.","journal-title":"Chin J Lung Cancer"},{"issue":"9","key":"12272_CR63","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1111\/1759-7714.13153","volume":"10","author":"A Nagy","year":"2019","unstructured":"Nagy A, M\u00fcller V, Kolonics-Farkas AM, Eszes N, Vincze K, Horvath G. Worse lung cancer outcome in patients with lower respiratory tract infection confirmed at time of diagnosis. Thorac Cancer. 2019;10(9):1819\u201326.","journal-title":"Thorac Cancer"},{"issue":"12","key":"12272_CR64","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1007\/s00268-018-4727-2","volume":"42","author":"S Shinohara","year":"2018","unstructured":"Shinohara S, Sugaya M, Onitsuka T, Machida K, Matsuo M, Tanaka F. Impact of postoperative pneumonia developing after discharge on long-Term follow-up for resected lung cancer. World J Surg. 2018;42(12):3979\u201387.","journal-title":"World J Surg"},{"key":"12272_CR65","doi-asserted-by":"publisher","first-page":"1119575\u2013","DOI":"10.3389\/fonc.2023.1119575","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Qin S, Liang Y, Yan L, Zheng M, Zeng Y, et al. Tumor grade-associated genomic mutations in Chinese patients with non-small cell lung cancer. Front Oncol. 2023;13:1119575\u2013.","journal-title":"Front Oncol"},{"issue":"6","key":"12272_CR66","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.21037\/tlcr-22-403","volume":"11","author":"D Lu","year":"2022","unstructured":"Lu D, Ma Z, Huang D, Zhang J, Li J, Zhi P, et al. Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study. Transl Lung Cancer Res. 2022;11(6):1119\u201331.","journal-title":"Transl Lung Cancer Res"},{"issue":"7","key":"12272_CR67","first-page":"723","volume":"23","author":"M Ganjali","year":"2021","unstructured":"Ganjali M, Kheirkhah B, Amini K. Expression of miRNA-601 and PD-L1 among Iranian patients with lung cancer and their relationship with smoking and mycoplasma infection. Cell J. 2021;23(7):723\u201329.","journal-title":"Cell J"},{"issue":"5","key":"12272_CR68","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00432-021-03547-0","volume":"147","author":"Y Dai","year":"2021","unstructured":"Dai Y, Zhong F, Liu W, Song Q, Hu W. Mycoplasma hyorhinis infection promotes tyrosine kinase inhibitor (TKI) resistance in lung adenocarcinoma patients. J Cancer Res Clin Oncol. 2021;147(5):1379\u201388.","journal-title":"J Cancer Res And Clin Oncol"},{"key":"12272_CR69","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.2147\/CMAR.S186217","volume":"11","author":"WM Xiong","year":"2019","unstructured":"Xiong WM, Xu QP, Xiao RD, Hu ZJ, Cai L, He F. Genome-wide DNA methylation and rna expression profiles identified RIPK3 as a differentially methylated gene in chlamydia pneumoniae infection lung carcinoma patients in China. Cancer Manag Res. 2019;11:5785\u201397.","journal-title":"Cancer Manag And Res"},{"issue":"17","key":"12272_CR70","doi-asserted-by":"publisher","first-page":"13462","DOI":"10.18632\/oncotarget.24008","volume":"9","author":"M Sun","year":"2018","unstructured":"Sun M, Bai Y, Zhao S, Liu X, Gao Y, Wang L, et al. Gram-negative bacteria facilitate tumor progression through TLR4\/IL-33 pathway in patients with non-small-cell lung cancer. Oncotarget. 2018;9(17):13462\u201373.","journal-title":"Oncotarget"},{"key":"12272_CR71","doi-asserted-by":"publisher","first-page":"150878","DOI":"10.1016\/j.bbrc.2024.150878","volume":"736","author":"SE Parfenyev","year":"2024","unstructured":"Parfenyev SE, Vishnyakov IE, Efimova TN, Daks AA, Shuvalov OY, Fedorova OA, et al. Effect of infection by mycoplasma arginini and mycoplasma salivarium on the oncogenic properties of lung cancer cell line A549. Biochem Biophys Res Commun. 2024;736:150878.","journal-title":"Biochem Biophys Res Commun"},{"key":"12272_CR72","doi-asserted-by":"publisher","first-page":"1046226\u2013","DOI":"10.3389\/fmicb.2022.1046226","volume":"13","author":"X Song","year":"2022","unstructured":"Song X, Liu B, Zhao G, Pu X, Liu B, Ding M, et al. Streptococcus pneumoniae promotes migration and invasion of A549 cells in vitro by activating mTORC2\/AKT through up-regulation of DDIT4 expression. Front Microbiol. 2022;13:1046226\u2013.","journal-title":"Front Microbiol"},{"issue":"1","key":"12272_CR73","doi-asserted-by":"publisher","first-page":"154\u2013","DOI":"10.1186\/s12859-021-04100-z","volume":"22","author":"S Hadifar","year":"2021","unstructured":"Hadifar S, Mostafaei S, Behrouzi A, Fateh A, Riahi P, Siadat SD, et al. Strain-specific behavior of mycobacterium tuberculosis in A549 lung cancer cell line. BMC Bioinf. 2021;22(1):154\u2013.","journal-title":"BMC Bioinf"},{"issue":"8","key":"12272_CR74","first-page":"379","volume":"76","author":"Z Li","year":"2021","unstructured":"Li Z, Chen X, Yi X. The effects of A549 and H1299 cell-derived exosomes on the proliferation and apoptosis of BEAS-2B cells. Pharmazie. 2021;76(8):379\u201387.","journal-title":"Pharmazie"},{"issue":"5","key":"12272_CR75","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.chom.2020.03.007","volume":"27","author":"S Tian","year":"2020","unstructured":"Tian S, Liu Y, Wu H, Liu H, Zeng J, Choi MY, et al. Genome-wide CRISPR screen identifies semaphorin 6A and 6B as receptors for paeniclostridium sordellii toxin TcsL. Cell Host Microbe. 2020;27(5):782\u201392.e7.","journal-title":"Cell Host And Microbe"},{"key":"12272_CR76","doi-asserted-by":"crossref","unstructured":"Boyarskikh UA, Shadrina AS, Smetanina MA, Tsepilov YA, Oscorbin IP, Kozlov VV, et al. Mycoplasma hyorhinis reduces sensitivity of human lung carcinoma cells to nutlin-3 and promotes their malignant phenotype. J Cancer Res Clin Oncol. 2018;144(7):1289\u2013300.","DOI":"10.1007\/s00432-018-2658-9"},{"issue":"6","key":"12272_CR77","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00262-017-1980-4","volume":"66","author":"K Hattar","year":"2017","unstructured":"Hattar K, Reinert CP, Sibelius U, G\u00f6kyildirim MY, Subtil FSB, Wilhelm J, et al. Lipoteichoic acids from staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro. Cancer Immunol Immunother. 2017;66(6):799\u2013809.","journal-title":"Cancer Immunol, Immunother"},{"issue":"8","key":"12272_CR78","first-page":"1","volume":"62","author":"J An","year":"2016","unstructured":"An J, Li Z, Dong Y, Ren J, Guo K. Methicillin-resistant Staphylococcus aureus infection exacerbates NSCLC cell metastasis by up-regulating TLR4\/MyD88 pathway. Cell Mol Biol. 2016;62(8):1\u20137.","journal-title":"Cellular And Mol Biol"},{"key":"12272_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2015.11.007","volume":"300","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Tripathi D, Kulkarni S, Rajan MGR. Mycobacterium tuberculosis H37Rv infected THP-1 cells induce epithelial mesenchymal transition (EMT) in lung adenocarcinoma epithelial cell line (A549). Cell Immunol. 2016;300:33\u201340.","journal-title":"Cellular Immunol"},{"issue":"2","key":"12272_CR80","doi-asserted-by":"publisher","first-page":"105923","DOI":"10.1016\/j.isci.2022.105923","volume":"26","author":"N Li","year":"2023","unstructured":"Li N, Zhou H, Holden VK, Deepak J, Dhilipkannah P, Todd NW, et al. Streptococcus pneumoniae promotes lung cancer development and progression. iScience. 2023;26(2):105923.","journal-title":"iScience"},{"issue":"1","key":"12272_CR81","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1158\/0008-5472.CAN-20-1994","volume":"81","author":"CH Liu","year":"2021","unstructured":"Liu CH, Chen Z, Chen K, Liao FT, Chung CE, Liu X, et al. Lipopolysaccharide-mediated chronic inflammation promotes tobacco carcinogen\u2013induced lung cancer and determines the efficacy of immunotherapy. Cancer Res. 2021;81(1):144\u201357.","journal-title":"Cancer Res"},{"issue":"2","key":"12272_CR82","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-018-1237-y","volume":"10","author":"S Cao","year":"2019","unstructured":"Cao S, Li J, Lu J, Zhong R, Zhong H. Mycobacterium tuberculosis antigens repress Th1 immune response suppression and promotes lung cancer metastasis through PD-1\/PDl-1 signaling pathway. Cell Death Dis. 2019;10(2):44.","journal-title":"Cell Death And Disease"},{"issue":"12","key":"12272_CR83","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.jtho.2019.07.023","volume":"14","author":"SD Gowing","year":"2019","unstructured":"Gowing SD, Chow SC, Cools-Lartigue JJ, Chen CB, Najmeh S, Goodwin-Wilson M, et al. Gram-negative pneumonia augments non\u2013small cell lung cancer metastasis through Host toll-like receptor 4 activation. J Thorac Oncol. 2019;14(12):2097\u2013108.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"12272_CR84","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/or.2017.5733","volume":"38","author":"Y Zhou","year":"2017","unstructured":"Zhou Y, Hu Z, Cao S, Yan B, Qian J, Zhong H. Concomitant mycobacterium tuberculosis infection promotes lung tumor growth through enhancing Treg development. Oncol Rep. 2017;38(2):685\u201392.","journal-title":"Oncol Rep"},{"issue":"8","key":"12272_CR85","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.21037\/jtd.2016.06.47","volume":"8","author":"M Ye","year":"2016","unstructured":"Ye M, Gu X, Han Y, Jin M, Ren T. Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients. J Thorac Disease. 2016;8(8):1943\u201355.","journal-title":"J Thorac Disease"},{"issue":"6","key":"12272_CR86","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/ijc.29111","volume":"136","author":"SC Chow","year":"2015","unstructured":"Chow SC, Gowing SD, Cools-Lartigue JJ, Chen CB, Berube J, Yoon HW, et al. Gram negative bacteria increase non-small cell lung cancer metastasis via toll-like receptor 4 activation and mitogen-activated protein kinase phosphorylation. Int J Cancer. 2015;136(6):1341\u201350.","journal-title":"Int J Cancer"},{"key":"12272_CR87","doi-asserted-by":"publisher","first-page":"1951620\u2013","DOI":"10.1155\/2022\/1951620","volume":"2022","author":"L Qian","year":"2022","unstructured":"Qian L, Wang F, Lu SM, Miao HJ, He X, Feng J, et al. A comprehensive prognostic and immune analysis of Ferroptosis-related genes identifies SLC7A11 as a novel prognostic biomarker in lung adenocarcinoma. J Immunol Res. 2022;2022:1951620\u2013.","journal-title":"J Immunol Res"},{"issue":"1","key":"12272_CR88","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12011-023-03912-9","volume":"202","author":"D Celeb\u0131","year":"2024","unstructured":"Celeb\u0131 D, Celeb\u0131 O, Aydin E, Baser S, G\u00fcler MC, Yildirim S, et al. Boron compound\u2013based treatments against multidrug-resistant bacterial infections in lung cancer in vitro Model. Biol Trace Elem Res. 2024;202(1):145\u201360.","journal-title":"Biol Trace Elem Res"},{"issue":"1","key":"12272_CR89","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40199-024-00505-2","volume":"32","author":"D Celebi","year":"2024","unstructured":"Celebi D, Celebi O, Taghizadehghalehjoughi A, Baser S, Ayd\u0131n E, Calina D, et al. Activity of zinc oxide and zinc borate nanoparticles against resistant bacteria in an experimental lung cancer model. DARU, J Pharm Sci. 2024;32(1):197\u2013206.","journal-title":"DARU, J Pharm Sci"},{"issue":"1","key":"12272_CR90","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12906-023-04222-2","volume":"23","author":"KM Kuppusamy","year":"2023","unstructured":"Kuppusamy KM, Selvaraj S, Singaravelu P, John CM, Racheal K, Varghese K, et al. Anti-microbial and anti-cancer efficacy of acetone extract of Rosa chinensis against resistant strain and lung cancer cell line. BMC Complement Med Ther. 2023;23(1):406.","journal-title":"BMC Complementary Med And Therapies"},{"issue":"6","key":"12272_CR91","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1021\/acsnano.2c12165","volume":"17","author":"Z Ma","year":"2023","unstructured":"Ma Z, Wang H, Shi Z, Yan F, Li Q, Chen J, et al. Inhalable GSH-Triggered Nanoparticles to treat commensal bacterial infection in in situ lung tumors. ACS Nano. 2023;17(6):5740\u201356.","journal-title":"ACS Nano"},{"issue":"10","key":"12272_CR92","doi-asserted-by":"publisher","first-page":"919","DOI":"10.5650\/jos.ess23101","volume":"72","author":"X Zeng","year":"2023","unstructured":"Zeng X, Zhao M, Yao H. Anti-lung cancer, anti-microbial, anti-\u03b1-glucosidase, anti-sorbitol dehydrogenase, and in silico studies of wogonoside and isoliquiritigenin as natural compounds. J Oleo Sci. 2023;72(10):919\u201327.","journal-title":"J Oleo Sci"},{"key":"12272_CR93","doi-asserted-by":"publisher","first-page":"113600\u2013","DOI":"10.1016\/j.ejmech.2021.113600","volume":"222","author":"E Ortega","year":"2021","unstructured":"Ortega E, P\u00e9rez-Arnaiz C, Rodr\u00edguez V, Janiak C, Busto N, Garc\u00eda B, et al. A 2-(benzothiazol-2-yl)-phenolato platinum(II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy\u2020. Eur J Med Chem. 2021;222:113600\u2013.","journal-title":"Eur J Med Chem"},{"key":"12272_CR94","doi-asserted-by":"publisher","first-page":"204993612412525","DOI":"10.1177\/20499361241252537","volume":"11","author":"S Khan","year":"2024","unstructured":"Khan S, Bilal H, Shafiq M, Zhang D, Awais M, Chen C, et al. Distribution of aspergillus species and risk factors for aspergillosis in mainland China: a systematic review. Ther Adv Infect Dis. 2024;11:20499361241252537\u2013.","journal-title":"Ther Adv Infect Disease"},{"key":"12272_CR95","doi-asserted-by":"crossref","unstructured":"Lucaciu S-R, Domokos B, Puiu R, Ruta V, Motoc SN, Rajnoveanu R, et al. Lung microbiome in lung cancer: a systematic review. 2024;12(12):2439.","DOI":"10.3390\/microorganisms12122439"},{"issue":"1","key":"12272_CR96","first-page":"15","volume":"24","author":"FC Santini","year":"2018","unstructured":"Santini FC, Hellmann MD. PD-1\/PD-L1 axis in lung cancer. Cancer J (U States). 2018;24(1):15\u201319.","journal-title":"Cancer J (U States)"},{"issue":"1","key":"12272_CR97","doi-asserted-by":"publisher","first-page":"e002571","DOI":"10.1136\/bmjresp-2024-002571","volume":"11","author":"P Chen","year":"2024","unstructured":"Chen P, Zheng X, Li C, Li J, Yang C, Feng Y, et al. Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLC. BMJ Open Respir Res. 2024;11(1):e002571.","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"12272_CR98","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3934\/publichealth.2023044","volume":"10","author":"EK Drokow","year":"2023","unstructured":"Drokow EK, Effah CY, Agboyibor C, Budu JT, Arboh F, Kyei-Baffour PA, et al. Microbial infections as potential risk factors for lung cancer: investigating the role of human papillomavirus and chlamydia pneumoniae. Aims Public Health. 2023;10(3):627\u201346.","journal-title":"Aims Public Health"},{"key":"12272_CR99","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/bs.ircmb.2017.07.007","volume":"335","author":"JP Mitchell","year":"2018","unstructured":"Mitchell JP, Carmody RJ. NF-\u03baB and the transcriptional control of inflammation. Int Rev Cell Mol Biol. 2018;335:41\u201384.","journal-title":"Int Rev Cell And Mol Biol"},{"key":"12272_CR100","doi-asserted-by":"crossref","unstructured":"Ubags NDJ, Marsland BJ. Mechanistic insight into the function of the microbiome in lung diseases. erj. 2017;1602467.","DOI":"10.1183\/13993003.02467-2016"},{"key":"12272_CR101","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.3389\/fimmu.2020.02120","volume":"11","author":"R S\u00e1nchez-Tarjuelo","year":"2020","unstructured":"S\u00e1nchez-Tarjuelo R, Cortegano I, Manosalva J, Rodr\u00edguez M, Ru\u00edz C, Al\u00eda M, et al. The TLR4-MyD88 signaling axis regulates lung monocyte differentiation pathways in response to streptococcus pneumoniae. Front Immunol. 2020;11:2120.","journal-title":"Front Immunol"},{"key":"12272_CR102","doi-asserted-by":"publisher","first-page":"103404","DOI":"10.1016\/j.critrevonc.2021.103404","volume":"164","author":"F Perrone","year":"2021","unstructured":"Perrone F, Belluomini L, Mazzotta M, Bianconi M, Di Noia V, Meacci F, et al. Exploring the role of respiratory microbiome in lung cancer: a systematic review. Crit Rev Oncol\/Hematol. 2021;164:103404.","journal-title":"Crit Rev In oncol\/Hematol"},{"issue":"5","key":"12272_CR103","doi-asserted-by":"publisher","first-page":"e0198223","DOI":"10.1371\/journal.pone.0198223","volume":"13","author":"L Gu","year":"2018","unstructured":"Gu L, Wang Z, Zuo J, Li H, Zha L. Prognostic significance of NF-\u03baB expression in non-small cell lung cancer: a meta-analysis. PLoS ONE. 2018;13(5):e0198223\u2013e.","journal-title":"PLoS One"},{"key":"12272_CR104","doi-asserted-by":"publisher","first-page":"576855","DOI":"10.3389\/fonc.2020.576855","volume":"10","author":"Z Ran","year":"2021","unstructured":"Ran Z, Liu J, Wang F, Xin C, Xiong B, Song Z. Pulmonary micro-ecological changes and potential microbial markers in lung cancer patients. Front Oncol. 2021;10:576855.","journal-title":"Front Oncol"},{"key":"12272_CR105","doi-asserted-by":"crossref","unstructured":"Salehi-Rad R, Dubinett SM. Understanding the mechanisms of immune-evasion by lung cancer in the context of chronic inflammation in emphysema. 2019;382\u201385.","DOI":"10.21037\/jtd.2019.01.22"},{"issue":"15","key":"12272_CR106","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1182\/blood-2016-06-722991","volume":"128","author":"IE Ahn","year":"2016","unstructured":"Ahn IE, Jerussi T, Farooqui M, Tian X, Wiestner A, Gea-Banacloche J. Atypical pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib. Blood. 2016;128(15):1940\u201343.","journal-title":"Blood"},{"issue":"17","key":"12272_CR107","doi-asserted-by":"publisher","first-page":"29406","DOI":"10.18632\/oncotarget.14707","volume":"8","author":"Y Wang","year":"2017","unstructured":"Wang Y, Wang M, Wang Q, Geng Z, Sun M. Incidence and risk of infections associated with EGFR-TKIs in advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomized controlled trials. Oncotarget. 2017;8(17):29406\u201315.","journal-title":"Oncotarget"},{"issue":"1","key":"12272_CR108","doi-asserted-by":"publisher","first-page":"288\u2013","DOI":"10.3892\/ol.2023.13874","volume":"26","author":"M Arai","year":"2023","unstructured":"Arai M, Abe M, Kitahara S, Sakuma N, Ohno I, Takahashi K, et al. Sequential administration of PD\u20111 inhibitor and cetuximab causes pneumonia. Oncol Lett. 2023;26(1):288\u2013.","journal-title":"Oncol Lett"},{"key":"12272_CR109","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2147\/OTT.S386807","volume":"15","author":"YS Chung","year":"2022","unstructured":"Chung YS, Lin YC, Hung MS, Ho MC, Fang YH. Clinical Impact of epidermal growth Factor receptor tyrosine kinase inhibitor associated Clostridioides difficile infection among patients with lung cancer. Onco Targets Ther. 2022;15:1563\u201371.","journal-title":"oncotargets And Ther"},{"issue":"7","key":"12272_CR110","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/bloodadvances.2020001678","volume":"4","author":"CE Ryan","year":"2020","unstructured":"Ryan CE, Cheng MP, Issa NC, Brown JR, Davids MS. Pneumocystis jirovecii pneumonia and institutional prophylaxis practices in CLL patients treated with BTK inhibitors. Blood Adv. 2020;4(7):1458\u201363.","journal-title":"Blood Adv"},{"issue":"1","key":"12272_CR111","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijrobp.2021.08.022","volume":"112","author":"T Mei","year":"2022","unstructured":"Mei T, Yang X, Yu Y, Tian X, Deng Q, Xu Y, et al. Secondary infections after diagnosis of severe radiation pneumonitis (SRP) among patients with non-small cell lung cancer: pathogen distributions, choice of empirical antibiotics, and the value of empirical antifungal treatment. Int J Radiat Oncol Biol Phys. 2022;112(1):179\u201387.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11 November","key":"12272_CR112","doi-asserted-by":"publisher","first-page":"e0242544","DOI":"10.1371\/journal.pone.0242544","volume":"15","author":"JA Stratmann","year":"2020","unstructured":"Stratmann JA, Lacko R, Ballo O, Shaid S, Gleiber W, Vehreschild MJGT, et al. Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer. PLoS ONE. 2020;15(11 November):e0242544\u2013e.","journal-title":"PLoS One"},{"key":"12272_CR113","doi-asserted-by":"crossref","unstructured":"Shestopalov AV, Kit OI, Davydov B VV, Zlatnik YM, Novikova EY, IA, et al. Interrelation between Pseudomonas aeruginosa quinolone signal and the level of immunoglobulins in the blood of patients with lung cancer. Uspehi Molekularnoj Onkologii. 2023;10(2):126\u201331.","DOI":"10.17650\/2313-805X-2023-10-2-126-131"},{"issue":"1","key":"12272_CR114","doi-asserted-by":"publisher","first-page":"174\u2013","DOI":"10.1007\/s12672-023-00784-2","volume":"14","author":"J Liang","year":"2023","unstructured":"Liang J, Liang R, Lei K, Huang J, Lin H, Wang M. Comparative analysis of single-cell transcriptome reveals heterogeneity in the tumor microenvironment of lung adenocarcinoma and brain metastases. Discover Oncol. 2023;14(1):174\u2013.","journal-title":"Discover Oncol"},{"key":"12272_CR115","doi-asserted-by":"publisher","first-page":"1183230\u2013","DOI":"10.3389\/fimmu.2023.1183230","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Chen J, Xia Y, Huang Y. A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma. Front Immunol. 2023;14:1183230\u2013.","journal-title":"Front Immunol"},{"issue":"3","key":"12272_CR116","doi-asserted-by":"publisher","first-page":"178","DOI":"10.24920\/004222","volume":"38","author":"HL Li","year":"2023","unstructured":"Li HL, Wang JX, Dai HW, Liu JJ, Liu ZY, Zou MY, et al. Prognostic prediction value and biological functions of non-apoptotic regulated cell death genes in lung adenocarcinoma. Chin Med Sci J. 2023;38(3):178\u201390.","journal-title":"Chin Med Sci J"},{"issue":"21","key":"12272_CR117","doi-asserted-by":"publisher","first-page":"6422","DOI":"10.7150\/jca.60118","volume":"12","author":"L Song","year":"2021","unstructured":"Song L, Chen Z, Zhang M, Zhang M, Lu X, Li C, et al. DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma. J Cancer. 2021;12(21):6422\u201328.","journal-title":"J Cancer"},{"key":"12272_CR118","doi-asserted-by":"publisher","first-page":"105394\u2013","DOI":"10.1016\/j.compbiomed.2022.105394","volume":"145","author":"Z Zheng","year":"2022","unstructured":"Zheng Z, Li Y, Lu X, Zhang J, Liu Q, Zhou D, et al. A novel mTOR-associated gene signature for predicting prognosis and evaluating tumor immune microenvironment in lung adenocarcinoma. Comput Biol Med. 2022;145:105394.","journal-title":"Comput In Biol And Med"},{"key":"12272_CR119","doi-asserted-by":"publisher","first-page":"823075\u2013","DOI":"10.3389\/fgene.2022.823075","volume":"13","author":"Q Guo","year":"2022","unstructured":"Guo Q, Xiao XY, Wu CY, Li D, Chen JL, Ding XC, et al. Clinical roles of risk Model based on differentially expressed genes in mesenchymal stem cells in prognosis and immunity of non-small cell lung cancer. Front Genet. 2022;13:823075\u2013.","journal-title":"Front Genet"},{"issue":"1","key":"12272_CR120","doi-asserted-by":"publisher","first-page":"8872","DOI":"10.1080\/21655979.2021.1987820","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Tang B, Hu J, Fang X, Bian H, Han J, et al. Neutrophils correlate with hypoxia microenvironment and promote progression of non-small-cell lung cancer. Bioengineered. 2021;12(1):8872\u201384.","journal-title":"Bioengineered"},{"issue":"9\u201310","key":"12272_CR121","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10495-019-01559-3","volume":"24","author":"N Mu","year":"2019","unstructured":"Mu N, Lei Y, Wang Y, Wang Y, Duan Q, Ma G, et al. Inhibition of SIRT1\/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells. Apoptosis. 2019;24(9\u201310):798\u2013811.","journal-title":"Apoptosis"},{"key":"12272_CR122","doi-asserted-by":"publisher","first-page":"e16292","DOI":"10.7717\/peerj.16292","volume":"11","author":"X Wei","year":"2023","unstructured":"Wei X, Liu Z, Shen Y, Dong H, Chen K, Shi X, et al. Semaphorin4A promotes lung cancer by activation of NF-\u03baB pathway mediated by PlexinB1. PeerJ. 2023;11:e16292\u2013e.","journal-title":"PeerJ"},{"issue":"1","key":"12272_CR123","doi-asserted-by":"publisher","first-page":"632\u2013","DOI":"10.1186\/s12885-022-09696-w","volume":"22","author":"J Jiang","year":"2022","unstructured":"Jiang J, Lu Y, Zhang F, Pan T, Zhang Z, Wan Y, et al. Semaphorin 4B promotes tumor progression and associates with immune infiltrates in lung adenocarcinoma. BMC Cancer. 2022;22(1):632\u2013.","journal-title":"BMC Cancer"},{"issue":"2","key":"12272_CR124","doi-asserted-by":"publisher","first-page":"21\u2013","DOI":"10.3892\/ijo.2022.5311","volume":"60","author":"M-Z Chen","year":"2022","unstructured":"Chen M-Z, Su L-Y, Ko P-H, Hsu M-H, Chuang L-L, Chen L-H, et al. Extracellular domain of semaphorin 5A serves a tumor\u2011suppressing role by activating interferon signaling pathways in lung adenocarcinoma cells. Int J Oncol. 2022;60(2):21\u2013.","journal-title":"Int J Oncol"},{"issue":"12","key":"12272_CR125","doi-asserted-by":"publisher","first-page":"95\u2013","DOI":"10.1038\/s41389-018-0105-z","volume":"7","author":"C-Y Shen","year":"2018","unstructured":"Shen C-Y, Chang Y-C, Chen L-H, Lin W-C, Lee Y-H, Yeh S-T, et al. The extracellular SEMA domain attenuates intracellular apoptotic signaling of semaphorin 6A in lung cancer cells. Oncogenesis. 2018;7(12):95\u2013.","journal-title":"Oncogenesis"},{"issue":"24","key":"12272_CR126","doi-asserted-by":"publisher","first-page":"e123093","DOI":"10.1172\/jci.insight.123093","volume":"3","author":"Y Kinehara","year":"2018","unstructured":"Kinehara Y, Nagatomo I, Koyama S, Ito D, Nojima S, Kurebayashi R, et al. Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells. JCI Insight. 2018;3(24):e123093\u2013e.","journal-title":"JCI Insight"},{"key":"12272_CR127","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lfs.2019.02.004","volume":"221","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Ma G, Yang X. HDAC5 promotes mycoplasma pneumoniae-induced inflammation in macrophages through NF-\u03baB activation. Life Sci. 2019;221:13\u201319.","journal-title":"Life Sci"},{"issue":"3","key":"12272_CR128","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/SHK.0000000000001372","volume":"53","author":"G Kasotakis","year":"2020","unstructured":"Kasotakis G, Kintsurashvili E, Galvan MD, Graham C, Purves JT, Agarwal S, et al. Histone deacetylase 7 inhibition in a murine model of gram-negative pneumonia-induced acute lung injury. Shock. 2020;53(3):344\u201351.","journal-title":"Shock"},{"issue":"9","key":"12272_CR129","first-page":"1305","volume":"35","author":"F Wang","year":"2022","unstructured":"Wang F, Zhou QY, Lu T. Imipenem cilastatin sodium\/meropenem in the treatment of patients with early lung cancer complicated severe pulmonary infection. Chin J Clin Res. 2022;35(9):1305\u201309.","journal-title":"Chin J Clin Res"},{"key":"12272_CR130","first-page":"5466853","volume":"2022","author":"M Zhang","year":"2022","unstructured":"Zhang M, Zhang Y, Sun Y, Wang S, Liang H, Han Y. Intratumoral microbiota impacts the first-line treatment efficacy and survival in non-small cell lung cancer patients free of lung infection. J Healthcare Eng. 2022;2022:5466853.","journal-title":"J Healthcare Eng"},{"issue":"7","key":"12272_CR131","first-page":"820","volume":"59","author":"P Zheng","year":"2024","unstructured":"Zheng P, Ji C, Wang Y, Chen X. Construction and validation of a postoperative lung infection prevention care program for lung cancer patients. Chin J Nurs. 2024;59(7):820\u201327.","journal-title":"Chin J Nurs"},{"issue":"4","key":"12272_CR132","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.21037\/jtd.2019.04.43","volume":"11","author":"H Deguchi","year":"2019","unstructured":"Deguchi H, Tomoyasu M, Shigeeda W, Kaneko Y, Kanno H, Saito H. Influence of prophylactic antibiotic duration on postoperative pneumonia following pulmonary lobectomy for non-small cell lung cancer. J Thorac Disease. 2019;11(4):1155\u201364.","journal-title":"J Thorac Disease"},{"issue":"26","key":"12272_CR133","doi-asserted-by":"publisher","first-page":"e1022","DOI":"10.1097\/MD.0000000000001022","volume":"94","author":"W-Y Chiou","year":"2015","unstructured":"Chiou W-Y, Hung S-K, Lai C-L, Lin H-Y, Su Y-C, Chen Y-C, et al. Effect of 23-valent pneumococcal polysaccharide vaccine inoculated during anti-cancer treatment period in elderly lung cancer patients on community-acquired pneumonia hospitalization. Medicine. 2015;94(26):e1022.","journal-title":"Medicine"},{"issue":"2","key":"12272_CR134","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0169-5002(97)00087-1","volume":"19","author":"A Nagatomo","year":"1998","unstructured":"Nagatomo A, Watanabe K, Kunikane H, Okamoto H, Kunitoh H. A randomized controled trial of sulfamethoxazole\/trimethoprim plus norfloxacin versus sulfamethoxazole\/trimethoprim alone for the prophylaxis of bacterial infection during chemotherapy for lung cancer. Lung Cancer. 1998;19(2):121\u201325.","journal-title":"Lung Cancer"},{"issue":"8","key":"12272_CR135","first-page":"1077","volume":"40","author":"Y Nakai","year":"1992","unstructured":"Nakai Y, Watanabe A, Motomiya M, Ebina A, Yoshida T, Onodera A, et al. Combined use of aztreonam and clindamycin in the treatment of respiratory infections associated with lung cancer. Chemotherapy. 1992;40(8):1077\u201384.","journal-title":"Chemotherapy"},{"issue":"2","key":"12272_CR136","first-page":"56","volume":"47","author":"N Hayama","year":"2022","unstructured":"Hayama N, Takiguchi H, Enokida K, Hattori S, Takahashi G, Takeuchi T, et al. Efficacy of prophylactic antibiotic use in preventing post-bronchoscopy pneumonia in lung cancer patients. Tokai J Exp Clin Med. 2022;47(2):56\u201359.","journal-title":"Tokai J Exp And Clin Med"},{"issue":"8","key":"12272_CR137","first-page":"534","volume":"28","author":"Y Jiang","year":"2016","unstructured":"Jiang Y, Zhong H, Li M, Song G. Preventive effect of salmeterol xinafoate and fluticasone propionate aerosol on radiation pneumonia in local advanced non-small cell lung cancer: a clinical study. Cancer Res Clinic. 2016;28(8):534\u20137and57.","journal-title":"Cancer Res And Clinic"},{"issue":"1","key":"12272_CR138","doi-asserted-by":"publisher","first-page":"1117\u2013","DOI":"10.1186\/s12879-024-10018-7","volume":"24","author":"EA Montazeri","year":"2024","unstructured":"Montazeri EA, Saki M, Savari M, Meghdadi H, Akrami S. Association between the presence of CRISPR-Cas system genes and antibiotic resistance in klebsiella pneumoniae isolated from patients admitted in Ahvaz teaching hospitals. BMC Infect Dis. 2024;24(1):1117\u2013.","journal-title":"BMC Infect Dis"},{"key":"12272_CR139","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.2147\/IDR.S494327","volume":"17","author":"MM Ahmed","year":"2024","unstructured":"Ahmed MM, Kayode HH, Okesanya OJ, Ukoaka BM, Eshun G, Mourid MR, et al. CRISPR-Cas systems in the fight against antimicrobial resistance: current status, potentials, and future directions. Infect Drug Resist. 2024;17:5229\u201345.","journal-title":"Infect And Drug Resist"},{"issue":"3","key":"12272_CR140","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40259-024-00656-3","volume":"38","author":"MS Rafiq","year":"2024","unstructured":"Rafiq MS, Shabbir MAB, Raza A, Irshad S, Asghar A, Maan MK, et al. CRISPR-Cas system: a new dawn to combat antibiotic resistance. BioDrugs. 2024;38(3):387\u2013404.","journal-title":"BioDrugs"},{"key":"12272_CR141","doi-asserted-by":"publisher","first-page":"100197\u2013","DOI":"10.1016\/j.crbiot.2024.100197","volume":"7","author":"M Abavisani","year":"2024","unstructured":"Abavisani M, Khoshrou A, Karbas Foroushan S, Sahebkar A. Chatting with artificial intelligence to combat antibiotic resistance: opportunities and challenges. Curr Res Biotechnol. 2024;7:100197\u2013.","journal-title":"Curr Res In Biotechnol"},{"issue":"3","key":"12272_CR142","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/1061186X.2024.2424895","volume":"33","author":"M Abavisani","year":"2025","unstructured":"Abavisani M, Khoshrou A, Eshaghian S, Karav S, Sahebkar A. Overcoming antibiotic resistance: the potential and pitfalls of drug repurposing. J Drug Targeting. 2025;33(3):341\u201367.","journal-title":"J Drug Targeting"},{"key":"12272_CR143","doi-asserted-by":"publisher","first-page":"100948\u2013","DOI":"10.1016\/j.drup.2023.100948","volume":"68","author":"M Abavisani","year":"2023","unstructured":"Abavisani M, Khayami R, Hoseinzadeh M, Kodori M, Kesharwani P, Sahebkar A. CRISPR-Cas system as a promising player against bacterial infection and antibiotic resistance. Drug Resist Updates. 2023;68:100948\u2013.","journal-title":"Drug Resist Updates"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12272-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12272-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:10:19Z","timestamp":1768342219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12272-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":143,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12272"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12272-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}